Stay updated on pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedThe study protocol document version was updated from v3.3.3 to v3.3.4. This is a minor administrative update to the study documents.SummaryDifference0.1%

- Check12 days agoChange DetectedRemoved related topics Prostate cancer and MedlinePlus Genetics from the page's related topics.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded Prostate cancer as a related topic under MedlinePlus Genetics and Wisconsin as a Location, and updated the page revision to v3.3.3. Removed the prior HHS Vulnerability Disclosure and the Wisconsin Locations entry (revision 3.3.2).SummaryDifference0.4%

- Check55 days agoChange DetectedPublication notes have been updated to say 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study,' and the Revision is v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page removes the warning about potential information delays due to a lapse in government funding. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedNo additions or deletions were observed on the Study Details page for NCT03600350. The content appears unchanged.SummaryDifference0.4%

Stay in the know with updates to pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.